Derivation of dopaminergic neurons from pluripotent stem cells

Progress in Brain Research

Volumn 200, Issue , 2012, Pages 243-263

  Studer, Lorenz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Directed differentiation; Embryonic stem cells; Induced pluripotent stem cells; Midbrain dopamine neurons

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHIR99021; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; LDN 193189; PROTEIN BCL XL; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR PITX3; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; EMBRYONIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84870268385     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59575-1.00011-9     Document Type: Chapter

References (112)

1. Alberi L., Sgado P., Simon H.H. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 2004, 131:3229-3236.
2. Alper J. Geron gets green light for human trial of ES cell-derived product. Nat. Biotechnol. 2009, 27:213-214.
3. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., Ericson J. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006, 124:393-405.
4. Ang S.L. Transcriptional control of midbrain dopaminergic neuron development. Development 2006, 133:3499-3506.
5. Arenas E., Åkerud P., Castro D.S., Holm P.C., Canals J.M., Snyder E.Y., Perlmann T., Wagner J. Engineering of a midbrain dopaminergic neuronal phenotype in neural stem cells. Eur. J. Neurosci. 2000, 12:261.
6. Aubert J., Stavridis M.P., Tweedie S., O'Reilly M., Vierlinger K., Li M., Ghazal P., Pratt T., Mason J.O., Roy D., Smith A. Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice. Proc. Natl. Acad. Sci. USA 2003, 100(Suppl. 1):11836-11841.
7. Bain G., Kitchens D., Yao M., Huettner J.E., Gottlieb D.I. Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 1995, 168:342-357.
8. Barberi T., Klivenyi P., Calingasan N.Y., Lee H., Kawamata H., Loonam K., Perrier A.L., Bruses J., Rubio M.E., Topf N., Tabar V., Harrison N.L., Beal M.F., Moore M.A., Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 2003, 21:1200-1207.
9. Björklund L.M., Sánchez-Pernaute R., Chung S., Andersson T., Chen I.Y.C., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 2002, 99:2344-2349.
10. Brons I.G.M., Smithers L.E., Trotter M.W.B., Rugg-Gunn P., Sun B., de Sousa Chuva., Lopes S.M., Howlett S.K., Clarkson A., Ahrlund-Richter L., Pedersen R.A., Vallier L. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
11. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Björklund A., Brooks D.J., David M.C., Oertel W.H., Quinn N.P., Rehncrona S., Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123:1380-1390.
12. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
13. Chambers S.M., Qi Y., Mica Y., Lee G., Zhang X.J., Niu L., Bilsland J., Cao L., Stevens E., Whiting P., Shi S.H., Studer L. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 2012, 30:715-720.
14. Chung S., Sonntag K.C., Andersson T., Björklund L.M., Park J.J., Kim D.W., Kang U.J., Isacson O., Kim K.S. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 2002, 16:1829-1838.
15. Chung S., Hedlund E., Hwang M., Kim D.W., Shin B.S., Hwang D.Y., Jung K.U., Isacson O., Kim K.S. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol. Cell. Neurosci. 2005, 28:241-252.
16. Conti L., Pollard S.M., Gorba T., Reitano E., Toselli M., Biella G., Sun Y.R., Sanzone S., Ying Q.L., Cattaneo E., Smith A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 2005, 3:1594-1606.
17. Davis C.A., Joyner A.L. Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. Genes Dev. 1988, 2:1736-1744.
18. Deacon T., Dinsmore J., Costantini L.C., Ratliff J., Isacson O. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol. 1998, 149:28-41.
19. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
20. Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton D.W., Thompson S., Smithies O. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987, 330:576-578.
21. Elkabetz Y., Panagiotakos G., Al Shamy G., Socci N.D., Tabar V., Studer L. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev. 2008, 22:152-165.
22. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
23. Fasano C.A., Studer L. Too much Sonic, too few neurons. Nat. Neurosci. 2009, 12:107-108.
24. Fasano C.A., Chambers S.M., Lee G., Tomishima M.J., Studer L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 2010, 6:336-347.
25. Ferrari D., Sanchez-Pernaute R., Lee H., Studer L., Isacson O. Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur. J. Neurosci. 2006, 24:1885-1896.
26. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 1998, 394:78-82.
27. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J., Lone T., Zhang Y., Snyder J.A., Wells T.H., Olson Ramig L., Thompson L., Mazziotta J.C., Huang S.C., Grafton S.T., Brooks D., Sawle G.V., Schroter G., Ansari A.A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 1992, 327:1549-1555.
28. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
29. Friling S., Andersson E., Thompson L.H., Jonsson M.E., Hebsgaard J.B., Nanou E., Alekseenko Z., Marklund U., Kjellander S., Volakakis N., Hovatta O., El M.A., Björklund A., Perlmann T., Ericson J. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA 2009, 106:7613-7618.
30. Fu Y.S., Cheng Y.C., Lin M.Y.A., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells 2006, 24:115-124.
31. Fuxe K., Hökfelt T., Ungerstedt T. Morphological and functional aspects of central monoamine neurons. Int. Rev. Neurobiol. 1970, 13:93-126.
32. Ganat Y., Calder E.L., Kriks S., Nelander J., Tu E.Y., Jia F., Battista D., Harrison N., Parmar M., Tomishima M.J., Rutishauser U., Studer L. Identification of embryonic stem cell derived midbrain dopaminergic neurons for engraftment. J. Clin. Invest. 2012, 122:2928-2939.
33. Gaspard N., Bouschet T., Hourez R., Dimidschstein J., Naeije G., van den Ameele J., Espuny-Camacho I., Herpoel A., Passante L., Schiffmann S.N., Gaillard A., Vanderhaeghen P. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 2008, 455:351-357.
34. Guzman J.N., Sanchez-Padilla J., Chan C.S., Surmeier D.J. Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 2009, 29:11011-11019.
35. Hauser R.A., Freeman T.B., Snow B.J., Nauert M., Gauger L., Kordower J.H., Olanow C.W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 1999, 56:179-187.
36. Hedlund E., Pruszak J., Lardaro T., Ludwig W., Viñuela A., Kim K.S., Isacson O. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008, 26:1526-1536.
37. Hynes M., Porter J.A., Chiang C., Chang D., Tessier-Lavigne M., Beachy P.A., Rosenthal A. Induction of midbrain dopaminergic neurons by sonic hedgehog. Neuron 1995, 15:35-44.
38. Hynes M., Poulsen K., Tessier-Lavigne M., Rosenthal A. Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell 1995, 80:95-101.
39. Isacson O., Deacon T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 1997, 20:477-482.
40. Jaeger I., Arber C., Risner-Janiczek J.R., Kuechler J., Pritzsche D., Chen I.C., Naveenan T., Ungless M.A., Li M. Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development 2011, 138:4363-4374.
41. Jeong Y., El-Jaick K., Roessler E., Muenke M., Epstein D.J. A functional screen for sonic hedgehog regulatory elements across a 1Mb interval identifies long-range ventral forebrain enhancers. Development 2006, 133:761-772.
42. Jeong Y., Leskow F.C., El-Jaick K., Roessler E., Muenke M., Yocum A., Dubourg C., Li X., Geng X., Oliver G., Epstein D.J. Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein. Nat. Genet. 2008, 40:1348-1353.
43. Johe K.K., Hazel T.G., Müller T., Dugich-Djordjevic M.M., McKay R.D.G. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 1996, 10:3129-3140.
44. Joksimovic M., Yun B.A., Kittappa R., Anderegg A.M., Chang W.W., Taketo M.M., McKay R.D., Awatramani R.B. Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat. Neurosci. 2009, 12:125-131.
45. Jung H., Lacombe J., Mazzoni E.O., Liem K.F., Grinstein J., Mahony S., Mukhopadhyay D., Gifford D.K., Young R.A., Anderson K.V., Wichterle H., Dasen J.S. Global control of motor neuron topography mediated by the repressive actions of a single hox gene. Neuron 2010, 67:781-796.
46. Kim J.H., Auerbach J.M., Rodriguez-Gómez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sánchez-Pernaute R., Bankiewicz K., McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.
47. Kim J.Y., Koh H.C., Lee J.Y., Chang M.Y., Kim Y.C., Chung H.Y., Son H., Lee Y.S., Studer L., McKay R., Lee S.H. Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J. Neurochem. 2003, 85:1443-1454.
48. Kim H., Lee G., Ganat Y., Papapetrou E.P., Lipchina I., Socci N.D., Sadelain M., Studer L. miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 2011, 8:695-706.
49. Kirkeby A., Grealish S., Wolf D.A., Nelander J., Wood J., Lundblad M., Lindvall O., Parmar M. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012, 1:703-714.
50. Kittappa R., Chang W.W., Awatramani R.B., McKay R.D. The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol. 2007, 5:e325.
51. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 1995, 332:1118-1124.
52. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., Yang L., Beal M.F., Surmeier D.J., Kordower J.H., Tabar V., Studer L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
53. Lee G., Studer L. Induced pluripotent stem cell technology for the study of human disease. Nat. Methods 2010, 7:25-27.
54. Lee S.-H., Lumelsky N., Studer L., Auerbach J.M., McKay R.D.G. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 2000, 18:675-679.
55. Li X.J., Du Z.W., Zarnowska E.D., Pankratz M., Hansen L.O., Pearce R.A., Zhang S.C. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005, 23:215-221.
56. Lindvall O. Dopaminergic neurons for Parkinson's therapy. Nat. Biotechnol. 2012, 30:56-58.
57. Lindvall O., Rehncrona S., Brundin P., Gustavii B., Åstedt B., Widner H., Lindholm T., Björklund A., Leenders K.L., Rothwell J.C. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 1989, 46:615-631.
58. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247:574-577.
59. Liste I., Garcia-Garcia E., Martinez-Serrano A. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J. Neurosci. 2004, 24:10786-10795.
60. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
61. McMahon A.P., Bradley A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990, 62:1073-1085.
62. Metzakopian E., Lin W., Salmon-Divon M., Dvinge H., Andersson E., Ericson J., Perlmann T., Whitsett J.A., Bertone P., Ang S.L. Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors. Development 2012, 139:2625-2634.
63. Munoz-Sanjuan I., Brivanlou A.H. Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 2002, 3:271-280.
64. Nguyen H.N., Byers B., Cord B., Shcheglovitov A., Byrne J., Gujar P., Kee K., Schule B., Dolmetsch R.E., Langston W., Palmer T.D., Pera R.R. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011, 8:267-280.
65. Nordstrom U., Maier E., Jessell T.M., Edlund T. An early role for Wnt signaling in specifying neural patterns of cdx and hox gene expression and motor neuron subtype identity. PLoS Biol. 2006, 4:e252.
66. Okabe S., Forsberg-Nilsson K., Spiro A.C., Segal M., McKay R.D.G. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 1996, 59:89-102.
67. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
68. Ono Y., Nakatani T., Sakamoto Y., Mizuhara E., Minaki Y., Kumai M., Hamaguchi A., Nishimura M., Inoue Y., Hayashi H., Takahashi J., Imai T. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 2007, 134:3213-3225.
69. Panman L., Andersson E., Alekseenko Z., Hedlund E., Kee N., Mong J., Uhde C.W., Deng Q., Sandberg R., Stanton L.W., Ericson J., Perlmann T. Transcription factor-induced lineage selection of stem-cell-derived neural progenitor cells. Cell Stem Cell 2011, 8:663-675.
70. Parish C.L., Castelo-Branco G., Rawal N., Tonnesen J., Sorensen A.T., Salto C., Kokaia M., Lindvall O., Arenas E. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J. Clin. Invest. 2008, 118:149-160.
71. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
72. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. From the cover: derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101:12543-12548.
73. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., Geny C., Samson Y., Hantraye P., Jeny R., Gaston A., Kéravel Y., Degos J.D., Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994, 117:487-499.
74. Piccini P., Brooks D.J., Björklund A., Gunn R.N., Grasby P.M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 1999, 2:1137-1140.
75. Placzek M., Briscoe J. The floor plate: multiple cells, multiple signals. Nat. Rev. Neurosci. 2005, 6:230-240.
76. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., Ben Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1134-1140.
77. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system (see comments). Science 1992, 255:1707-1710.
78. Robinton D.A., Daley G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305.
79. Saha K., Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009, 5:584-595.
80. Sanchez-Freire V., Ebert A.D., Kalisky T., Quake S.R., Wu J.C. Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns. Nat. Protoc. 2012, 7:829-838.
81. Sánchez-Pernaute R., Studer L., Bankiewicz K.S., Major E.O., McKay R.D. In vitro generation and transplantation of precursor-derived human dopamine neurons. J. Neurosci. Res. 2001, 65:284-288.
82. Sánchez-Pernaute R., Studer L., Ferrari D., Perrier A.L., Lee H., Viñuela A., Isacson O. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno1) in rat and primate striatum. Stem Cells 2005, 23:914-922.
83. Sanchez-Pernaute R., Lee H., Patterson M., Reske-Nielsen C., Yoshizaki T., Sonntag K.C., Studer L., Isacson O. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain 2008, 131:2127-2139.
84. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., Mickunas E., Gay R., Klimanskaya I., Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
85. Shim J.W., Koh H.C., Chang M.Y., Roh E., Choi C.Y., Oh Y.J., Son H., Lee Y.S., Studer L., Lee S.H. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J. Neurosci. 2004, 24:843-852.
86. Smidt M.P., Van Schaick H.A., Lanctot C., Tremblay J.J., Cox J.J., Van der Kleij A.M., Wolterink G., Drouin J., Burbach J.H. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13305-13310.
87. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
88. Soldner F., Laganiere J., Cheng A.W., Hockemeyer D., Gao Q., Alagappan R., Khurana V., Golbe L.I., Myers R.H., Lindquist S., Zhang L., Guschin D., Fong L.K., Vu B.J., Meng X., Urnov F.D., Rebar E.J., Gregory P.D., Zhang H.S., Jaenisch R. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011, 146:318-331.
89. Sonntag K.C., Pruszak J., Yoshizaki T., van A.J., Sanchez-Pernaute R., Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the BMP antagonist noggin. Stem Cells 2007, 25:411-418.
90. Studer L., Psylla M., Buhler B., Evtouchenko L., Vouga C.M., Leenders K.L., Seiler R.W., Spenger C. Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: a tool to assess dopaminergic tissue prior to grafting. Brain Res. Bull. 1996, 41:143-150.
91. Studer L., Tabar V., McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1998, 1:290-295.
92. Takagi Y., Takahashi J., Saiki H., Morizane A., Hayashi T., Kishi Y., Fukuda H., Okamoto Y., Koyanagi M., Ideguchi M., Hayashi H., Imazato T., Kawasaki H., Suemori H., Omachi S., Iida H., Itoh N., Nakatsuji N., Sasai Y., Hashimoto N. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 2005, 115:102-109.
93. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
94. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
95. Tao W., Lai E. Telencephalon-restricted expression of BF-1, a new member of the HNF-3/fork head gene family, in the developing rat brain. Neuron 1992, 8:957-966.
96. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
97. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
98. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
99. Trzaska K.A., Kuzhikandathil E.V., Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007, 25:2797-2808.
100. Wakayama T., Tabar V., Rodriguez I., Perry A.C., Studer L., Mombaerts P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001, 292:740-743.
101. Watanabe K., Kamiya D., Nishiyama A., Katayama T., Nozaki S., Kawasaki H., Watanabe Y., Mizuseki K., Sasai Y. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005, 8:288-296.
102. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., Takahashi J.B., Nishikawa S., Nishikawa S., Muguruma K., Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25:681-686.
103. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 2008, 105:5856-5861.
104. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
105. Xi J., Liu Y., Liu H., Chen H., Emborg M.E., Zhang S.C. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012, 30(8):1655-1663.
106. Yan J., Studer L., McKay R.D.G. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem. 2001, 76:307-311.
107. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23:781-790.
108. Yang D., Zhang Z.J., Oldenburg M., Ayala M., Zhang S.C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26:55-63.
109. Ye W.L., Shimamura K., Rubenstein J.R., Hynes M.A., Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998, 93:755-766.
110. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
111. Zetterström R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-250.
112. Zhang S.C., Wernig M., Duncan I.D., Brustle O., Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1129-1133.